Genic Co. Ltd (123330) — Capital Reinvestment Ratio
Genic Co. Ltd (123330) has a Capital Reinvestment Ratio of 0.12x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩7.70 Billion) in capital expenditures (₩958.13 Million). Check Genic Co. Ltd (123330) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Genic Co. Ltd Capital Reinvestment Ratio (2012–2025)
This chart tracks Genic Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see 123330 cash generation efficiency.
Annual Capital Reinvestment Ratio for Genic Co. Ltd (2012–2025)
Year-by-year Capital Reinvestment Ratio for Genic Co. Ltd from 2012 to 2025. See 123330 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.13x | ₩20.65 Billion | ₩2.68 Billion | ▼ -97.9% |
| 2024 | 6.06x | ₩272.46 Million | ₩1.65 Billion | ▼ -24.2% |
| 2022 | 8.00x | ₩177.94 Million | ₩1.42 Billion | ▲ +3984.9% |
| 2021 | 0.20x | ₩3.32 Billion | ₩650.83 Million | ▼ -94.6% |
| 2020 | 3.62x | ₩212.66 Million | ₩769.27 Million | ▲ +499.4% |
| 2019 | 0.60x | ₩1.38 Billion | ₩830.95 Million | ▼ -86.5% |
| 2016 | 4.48x | ₩1.93 Billion | ₩8.63 Billion | ▲ +20.7% |
| 2015 | 3.71x | ₩3.63 Billion | ₩13.48 Billion | ▲ +89.2% |
| 2014 | 1.96x | ₩5.80 Billion | ₩11.39 Billion | ▼ -17.0% |
| 2013 | 2.36x | ₩3.68 Billion | ₩8.69 Billion | ▲ +130.9% |
| 2012 | 1.02x | ₩4.31 Billion | ₩4.41 Billion | — |